GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » PB Ratio

Bora Pharmaceuticals Co (TPE:6472) PB Ratio : 5.10 (As of Apr. 09, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-09), Bora Pharmaceuticals Co's share price is NT$638.00. Bora Pharmaceuticals Co's Book Value per Share for the quarter that ended in Dec. 2024 was NT$125.14. Hence, Bora Pharmaceuticals Co's PB Ratio of today is 5.10.

Good Sign:

Bora Pharmaceuticals Co Ltd stock PB Ratio (=5.53) is close to 2-year low of 5.53.

The historical rank and industry rank for Bora Pharmaceuticals Co's PB Ratio or its related term are showing as below:

TPE:6472' s PB Ratio Range Over the Past 10 Years
Min: 1.37   Med: 4.41   Max: 12
Current: 5.67

During the past 13 years, Bora Pharmaceuticals Co's highest PB Ratio was 12.00. The lowest was 1.37. And the median was 4.41.

TPE:6472's PB Ratio is ranked worse than
87.29% of 936 companies
in the Drug Manufacturers industry
Industry Median: 1.78 vs TPE:6472: 5.67

During the past 12 months, Bora Pharmaceuticals Co's average Book Value Per Share Growth Rate was 39.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 57.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 48.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 37.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bora Pharmaceuticals Co was 57.20% per year. The lowest was 7.40% per year. And the median was 38.50% per year.

Back to Basics: PB Ratio


Bora Pharmaceuticals Co PB Ratio Historical Data

The historical data trend for Bora Pharmaceuticals Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bora Pharmaceuticals Co PB Ratio Chart

Bora Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.31 3.99 6.87 7.11 6.01

Bora Pharmaceuticals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.11 7.59 8.72 6.43 6.01

Competitive Comparison of Bora Pharmaceuticals Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bora Pharmaceuticals Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bora Pharmaceuticals Co's PB Ratio falls into.


;
;

Bora Pharmaceuticals Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Bora Pharmaceuticals Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=638.00/125.144
=5.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Bora Pharmaceuticals Co  (TPE:6472) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Bora Pharmaceuticals Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bora Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines